Title for Certificate
Which meeting are you claiming credit for?
*
Wednesday, March 19th - Mount Sinai
Wednesday, March 19th – Duke Health
Thursday, April 3rd - UF Jacksonville
Tuesday, May 6th - Johns Hopkins
Wednesday, May 7th - University of Mississippi Medical Center
Tuesday, May 13th - University of Illinois
Wednesday, May 14th - Northwell Health
Wednesday, May 14th - NYU Langone
Monday, May 19th - University of Kentucky
Wednesday, May 28th - Mount Sinai South Nassau
Tuesday, June 10th - Newark Beth Israel
Thursday, June 19th - Rush University
Wednesday, July 23rd - University Hospitals Cleveland
Wednesday, July 23rd - Oklahoma Heart Hospital
Tuesday, July 29th - Cornell
Wednesday, August 6th - Virginia Heart
Tuesday, September 23rd - RWJ Barnabas Health
Wednesday, October 1st - The University of Alabama at Birmingham
Wednesday, October 1st - Ascension Nashville
Thursday, October 9th - Henry Ford
Date 1
Date 2
Date 3
Date 4
Date 5
Date 6
Date 7
Date 8
Date 9
Date 10
Date 11
Date 12
Date 13
Date 14
Date 15
Date 16
Date 17
Date 18
Date 19
Name
*
First Name
Last Name
Degree(s)
*
Email
*
example@example.com
Institution
Country
1. What proportion of obstructive HCM patients demonstrate LVOT obstruction at rest and with provocation, respectively?
*
a. 50% and 70%
b. 25% and 50%
c. 10% and 25%
d. 25% and 70%
2. During a pre-participation evaluation, a college American style football player is found to have hypertrophic cardiomyopathy. Electrocardiogram and resting transthoracic echocardiogram are consistent with a diagnosis of apical hypertrophic cardiomyopathy. Which of the following statements regarding the patient’s athletic activities is most consistent with current ACC/AHA guidelines?
*
a. The patient should cease all structured athletic activities due to the increased risk of sudden death during sport participation in the setting of HCM.
b. The patient should only participate in low-intensity, low-impact sports such as bowling, golf, or curling.
c. The patient should be assessed by an expert provider with experience in assessing and treating athletes with HCM. For some athletes with HCM, return to athletic participation (including vigorous exercise) is reasonable.
d. If the patient agrees to have an ICD placed, he can be cleared to return to playing competitive soccer.
e. The patient should be assessed by an expert provider with experience in assessing and treating athletes with HCM. For athletes with HCM who are asymptomatic, a clearance to return to play is reasonable and requires no further testing.
3. You are evaluating a 47-year-old female with HCM. She has no symptoms and no high-risk features for sudden cardiac arrest. Which statement is true regarding her plans to resume regular exercise?
*
a. The long-term cardiac benefits of exercise in HCM are negated by the increased risk of ventricular arrhythmias and death among patients with HCM who exercise.
b. Exercise is beneficial for the cardiac and overall health of patients with HCM but should be done at lower volumes and intensities as compared without HCM.
c. Patients with HCM should not exceed 50% of their age-predicted maximal heart rate during exercise as this is associated with an increased risk of ventricular arrhythmias.
d. She should work towards a goal of achieving 150-300 minutes per week of moderate intensity physical exercise.
4. The primary purpose of Risk Evaluation and Mitigation Strategies (REMS) programs is:
*
a. To track volume of usage of a newly approved medication
b. To confirm that a newly approved medicine is only used on label
c. To ensure that the benefits of a medication outweigh its risks
d. To support a pending application of a label expansion for a medication
Learning Objectives
Rows
Poor
Fair
Good
Very Good
Excellent
An improved understanding of the prevalence, pathophysiology, unmet patient needs, and natural course of HCM
Improved confidence and competence in diagnostic skill for recognizing HCM
A clear understanding of the differences between symptom management and pathophysiology-targeted treatment for patients with HCM
Practice-pertinent awareness of the most recent clinical data on the efficacy and safety of CMIs in the management of HCM, including differences in study design and clinical applicability of endpoints
Familiarity with the most current specialty society guidelines addressing the management of HCM
Do you feel this activity was fair balanced and free of commercial bias?
Yes
No
If no, please explain:
This educational activity will result in a change in my role as a healthcare team member.
Yes
No
N/A
This educational activity will result in a change in my practice behavior.
Yes
No
N/A
Based on your participation in this activity, choose the statement(s) that applies to how your role as a healthcare team member will change:
I gained new strategies/skills/information that my team can apply to practice
I plan to implement new strategies/skills/information in my practice
I will be more competent in my team’s management of patient care
I will improve my communication with the healthcare team
What factors beyond clinical care that effect the health of your patients does your team experience?
Submit
Should be Empty: